Establishment of a Risk Signature Based on m6A RNA Methylation Regulators That Predicts Poor Prognosis in Renal Cell Carcinoma

References

• Rossi SH, Klatte T, Usher-Smith J, Stewart GD. Epidemiology and screening for renal cancer. Review. World J Urol. 2018;36(9):1341–1353. doi:10.1007/s00345-018-2286-7
   PubMed Web of Science ®Google Scholar
• Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Ficarra V. Renal cell carcinoma. Nat Rev Disease Primers. 2017;3:17009.
   PubMed Web of Science ®Google Scholar
• Srinivasan R, Ricketts CJ, Sourbier C, Linehan WM. New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of disease. Clin Cancer Res. 2015;21(1):10–17. doi:10.1158/1078-0432.CCR-13-2993
   PubMed Web of Science ®Google Scholar
• Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. research support, N.I.H., extramural. N Engl J Med. 2016;374(2):135–145. doi:10.1056/NEJMoa1505917
   PubMed Web of Science ®Google Scholar
• Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Research Support, N.I.H., Intramural Review. Nat Rev Urol. 2010;7(5):245–257. doi:10.1038/nrurol.2010.46
   PubMed Web of Science ®Google Scholar
• Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913–924. doi:10.1016/j.eururo.2015.01.005
   PubMed Web of Science ®Google Scholar
• Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Research Support, Non-U.S. Gov’t Review. Cancer Treat Rev. 2008;34(3):193–205. doi:10.1016/j.ctrv.2007.12.001
   PubMed Web of Science ®Google Scholar
• Dogan B, Canda AE, Akbulut Z, Balbay MD. Re: histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol. 2010;184(5):2211–2212. doi:10.1016/j.juro.2010.06.125
   PubMed Web of Science ®Google Scholar
• Pantuck AJ, Zisman A, Belldegrun AS. Belldegrun as. the changing natural history of renal cell carcinoma. J Urol. 2001;166(5):1611–1623. doi:10.1016/S0022-5347(05)65640-6
   PubMed Web of Science ®Google Scholar
• Deng X, Su R, Weng H, Huang H, Li Z, Chen J. RNA N(6)-methyladenosine modification in cancers: current status and perspectives. Review. Cell Res. 2018;28(5):507–517. doi:10.1038/s41422-018-0034-6
   PubMed Web of Science ®Google Scholar
• He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Research Support, Non-U.S. Gov’t Review. Mol Cancer. 2019;18(1):176. doi:10.1186/s12943-019-1109-9
   PubMed Web of Science ®Google Scholar
• Gong D, Zhang J, Chen Y, et al. The m(6)A-suppressed P2RX6 activation promotes renal cancer cells migration and invasion through ATP-induced Ca(2+) influx modulating ERK1/2 phosphorylation and MMP9 signaling pathway. J Exp Clin Cancer Res. 2019;38(1):233. doi:10.1186/s13046-019-1223-y
   PubMedGoogle Scholar
• Li X, Tang J, Huang W, et al. The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma. Oncotarget. 2017;8(56):96103–96116. doi:10.18632/oncotarget.21726
   PubMedGoogle Scholar
• Jia G, Fu Y, Zhao X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t. Nat Chem Biol. 2011;7(12):885–887. doi:10.1038/nchembio.687
   PubMed Web of Science ®Google Scholar
• Liu J, Yue Y, Han D, et al. A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 10(2):93–95. doi:10.1038/nchembio.1432
   PubMed Web of Science ®Google Scholar
• Ping XL, Sun BF, Wang L, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Research Support, Non-U.S. Gov’t. Cell Res. 2014;24(2):177–189. doi:10.1038/cr.2014.3
   PubMed Web of Science ®Google Scholar
• Wen J, Lv R, Ma H, et al. Zc3h13 regulates nuclear rna m 6 a methylation and mouse embryonic stem cell self-renewal. Mol Cell. 2018;69(6):1028–1038.e6. doi:10.1016/j.molcel.2018.02.015
   PubMed Web of Science ®Google Scholar
• Yue Y, Liu J, Cui X, Cao J, Liu J. VIRMA mediates preferential m6A mRNA methylation in 3′UTR and near stop codon and associates with alternative polyadenylation. Cell Discovery. 2018;4(1):10. doi:10.1038/s41421-018-0019-0
   PubMed Web of Science ®Google Scholar
• Hsu PJ, Zhu Y, Ma H, et al. Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017;27(9):1115–1127. doi:10.1038/cr.2017.99
   PubMed Web of Science ®Google Scholar
• Liu N, Dai Q, Zheng G, He C, Parisien M, Pan T. N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t. Nature. 2015;518(7540):560–564. doi:10.1038/nature14234
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Research Support, Non-U.S. Gov’t. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Wilkerson MD, Neil HD. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;12:12.
   Google Scholar
• Simon N, Friedman J, Hastie T, Tibshirani R. Regularization paths for cox’s proportional hazards model via coordinate descent. J Stat Softw. 2011;39(5):1–13. doi:10.18637/jss.v039.i05
   PubMed Web of Science ®Google Scholar
• Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36. doi:10.1148/radiology.143.1.7063747
   PubMed Web of Science ®Google Scholar
• Kaplan S, Ekici S, Dogan R, Demircin M, Ozen H, Pasaoglu I. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Am J Surg. 2002;183(3):292–299. doi:10.1016/s0002-9610(02)00782-1
   PubMed Web of Science ®Google Scholar
• Winkler GS. The mammalian anti-proliferative BTG/Tob protein family. J Cell Physiol. 2010;222(1):66–72. doi:10.1002/jcp.21919
   PubMed Web of Science ®Google Scholar
• Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Meta-Analysis Research Support, U.S. Gov’t, P.H.S. Int J Cancer. 2005;114(1):101–108. doi:10.1002/ijc.20618
   PubMed Web of Science ®Google Scholar
• Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3ʹ UTRs and near stop codons. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S. Cell. 2012;149(7):1635–1646. doi:10.1016/j.cell.2012.05.003
   PubMed Web of Science ®Google Scholar
• Fu Y, Dominissini D, Rechavi G, He C. Gene expression regulation mediated through reversible m6A RNA methylation. Nat Rev Genet. 2014;15(5):293–306. doi:10.1038/nrg3724
   PubMed Web of Science ®Google Scholar
• Gerken T, Girard CA, Tung YCL, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science. 2007;318(5855):1469–1472. doi:10.1126/science.1151710
   PubMed Web of Science ®Google Scholar
• Sigurdson AJ, Brenner AV, Roach JA, et al. Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population. Carcinogenesis. 2016;37(7):677–684. doi:10.1093/carcin/bgw047
   PubMed Web of Science ®Google Scholar
• Tan A, Dang Y, Chen G, Mo Z. Overexpression of the fat mass and obesity associated gene (FTO) in breast cancer and its clinical implications. Int J Clin Exp Pathol. 2015;8(10):13405–13410.
   PubMed Web of Science ®Google Scholar
• Li Z, Weng H, Su R, et al. FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-Methyladenosine RNA demethylase. research support, Non-U.S. Gov’t Research Support, N.I.H., Extramural. Cancer Cell. 2017;31(1):127–141. doi:10.1016/j.ccell.2016.11.017
   PubMed Web of Science ®Google Scholar
• Zhou S, Bai ZL, Xia D, et al. FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting beta-catenin through mRNA demethylation. Research Support, Non-U.S. Gov’t. Mol Carcinog. 2018;57(5):590–597. doi:10.1002/mc.22782
   PubMed Web of Science ®Google Scholar
• Bansal H, Yihua Q, Iyer SP, Ganapathy S, Bansal S. WTAP is a Novel Oncogenic Protein in Acute Myeloid Leukemia. Leukemia. 2014;28(12):1171–1174. doi:10.1038/leu.2014.16
   PubMed Web of Science ®Google Scholar
• Ma JZ, Yang F, Zhou CC, et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing. Research Support, Non-U.S. Gov’t. Hepatology. 2017;65(2):529–543. doi:10.1002/hep.28885
   PubMed Web of Science ®Google Scholar
• Chen M, Wei L, Law CT, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Research Support, Non-U.S. Gov’t. Hepatology. 2018;67(6):2254–2270. doi:10.1002/hep.29683
   PubMed Web of Science ®Google Scholar
• Lin S, Choe J, Du P, Triboulet R, Gregory RI. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62:3. doi:10.1016/j.molcel.2016.03.021
   Web of Science ®Google Scholar
• Cui Q, Shi H, Ye P, et al. m(6)A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells. Research Support, Non-U.S. Gov’t Research Support, N.I.H., Extramural. Cell Rep. 2017;18(11):2622–2634. doi:10.1016/j.celrep.2017.02.059
   PubMed Web of Science ®Google Scholar
• Schwartz S, MR M, et al. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5ʹ sites. Cell Rep. 2014;8(1):284. doi:10.1016/j.celrep.2014.05.048
   PubMed Web of Science ®Google Scholar
• Li BQ, Huang S, Shao QQ, et al. WT1-associated protein is a novel prognostic factor in pancreatic ductal adenocarcinoma. Oncol Lett. 2017;13(4):2531–2538. doi:10.3892/ol.2017.5784
   PubMed Web of Science ®Google Scholar
• Weng H, Huang H, Wu H, et al. METTL14 inhibits hematopoietic stem/progenitor differentiation and promotes leukemogenesis via mRNA mA Modification. Cell Stem Cell. 2018;22(2):191–205.e9. doi:10.1016/j.stem.2017.11.016
   PubMed Web of Science ®Google Scholar